Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. Types and predictors of interferon/ribavirin induced cardiac complications in the Egyptian patients with chronic hepatitis C virus
- Ibtesam Ibrahim El-Dosouky
- Soha Abdel-Moneim El Hawari
- Mohamed Hassan Emara
- Emad Fawzi Hamed
2. Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C
- Reza Karbasi-Afshar
- Amin Saburi
3. Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review
- Wenxue Zhao
- Fanpu Ji
- Shanshan Yu
- Zongfang Li
- Hong Deng
4. Persistently altered liver test results in hepatitis C patients after sustained virological response with direct‐acting antivirals
- A. Olveira
- L. Domínguez
- J. Troya
- A. Arias
- F. Pulido
- P. Ryan
- L. M. Benítez
- J. González‐García
- M. L. Montes
5. Triple Combination with Direct Acting Antivirals in the Treatment of Hepatitis C Does not Prolong the QT Interval
- Jakub Šimka
- Radek Pudil
- Monika Fialová
- Filip Varhaník
- Stanislav Plíšek
- Petr Pařízek
6. Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological Response
- Abdul-Quddus Mohammed
- Ranshaka Auckle
- Hai-Ling Li
- Si-Ling Xu
- Lu Liu
- Dong-Dong Zhao
- Wen-Liang Che
7. Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia
- Arezoo Khosravi
- Hamidreza Karimi‐Sari
- Mahdi Abedi‐Andani
- Bita Behnava
- Ali Namvar
- Ali Anvar
- Seyed Moayed Alavian
8. Factors associated with treatment interruption for hepatitis C
- Luciana Oliveira de Rezende Melo
- Denise Leite Maia Monteiro
- Nádia Cristina Pinheiro Rodrigues